MoneyWorks4Me

Caplin Point Laboratories informs about press release

03 Mar 2023 Evaluate
Caplin Point Laboratories has informed that it enclosed Press Release regarding grant of USFDA approval for its Abbreviated New Drug Application (ANDA) Rocuronium Bromide Injection to its Subsidiary Caplin Steriles.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..